Global Gaucher Disease Market Analysis

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Gaucher Disease Market Analysis

  • Pharmaceutical
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Gaucher disease is a hereditary metabolic disease in which glucocerebroside, a form of fat (lipid), is unable to breakdown. Glucocerebrosidase is an enzyme that breaks down and reprocesses glucocerebroside in the human body. Gaucher disease is caused by mutations in the GBA gene, which results in very low levels of the glucocerebrosidase enzyme, which causes glucocerebroside breakdown to be slow. Gaucher disease is characterized as one of three types: type 1, type 2, or type 3. Gaucher disease is classified into type 1, type 2, and type 3. Type 1 is the most frequent, whereas type 2 and type 3 are less common.

Filled Map Analysis